To rule out the possibility that our conclusions were affected by this limitation, we next analyzed FAAH protein expression in a second TMA (i.e., TMA #2) containing primary non-treated breast tumor samples exclusively of the luminal subtype (n = 276) and matched synchronous lymph node (LN) metastatic samples. This evidence concerns the gene FAAH and breast neoplasm.